A randomised phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization

被引：0
作者：
Vogl, T. [1 ]
Naguib, N. [1 ]
Lencioni, R. [2 ]
Malagari, K. [3 ]
Pilleul, F. [4 ]
Denys, A. [5 ]
Watkinson, A. [6 ]
Lammer, J. [7 ]
机构：
[1] Univ Frankfurt Klinikum, Inst Diagnost & Intervent Radiol, D-6000 Frankfurt, Germany
[2] Univ Pisa, Diagnost Imaging & Intervent Dept Liver Transplan, Pisa, Italy
[3] Univ Athens, Athens, Greece
[4] Ctr Hosp Univ, Dept Imagerie Digest, Lyon, France
[5] Ctr Hosp Univ, Dept Radiol, Lausanne, Switzerland
[6] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
[7] Univ Vienna, Vienna, Austria
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71227-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
[31]   Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma [J].
Ran You ;
Bin Leng ;
Chendong Wang ;
Zeyu Yu ;
Lingfeng Diao ;
Ya Lu ;
Qingyu Xu ;
Guowen Yin .
Discover Oncology, 16 (1)
[32]   Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma [J].
Pawlik, Timothy M. ;
Reyes, Diane K. ;
Cosgrove, David ;
Kamel, Ihab R. ;
Bhagat, Nikhil ;
Geschwind, Jean-Francois H. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) :3960-3967
[33]   Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization [J].
Kuang, Donglin ;
Zhang, Nan ;
Zhang, Mengfan ;
Li, Hao ;
Han, Xinwei ;
Ren, Jianzhuang ;
Duan, Xuhua .
FRONTIERS IN ONCOLOGY, 2023, 13
[34]   Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. [J].
Rose, DM ;
Chapman, WC ;
Brockenbrough, AT ;
Wright, JK ;
Rose, AT ;
Meranze, S ;
Mazer, M ;
Blair, T ;
Blanke, CD ;
Debelak, JP ;
Pinson, CW .
HEPATOLOGY, 1998, 28 (04) :766A-766A
[35]   Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma [J].
Reis, Stephen P. ;
Sutphin, Patrick D. ;
Singal, Amit G. ;
Grzybowski, Richard ;
Fisher, Stephen ;
Ball, Christopher ;
Xi, Yin ;
Grewal, Simer ;
Kalva, Sanjeeva P. .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2017, 41 (02) :289-293
[36]   The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis [J].
Han, Tao ;
Yang, Xiaodan ;
Zhang, Yue ;
Li, Gao ;
Liu, Lu ;
Chen, Tingsong ;
Zheng, Zhendong .
BIOSCIENCE TRENDS, 2019, 13 (05) :374-381
[37]   Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma [J].
Yi-Sheng Liu ;
Chia-Ying Lin ;
Ming-Tsung Chuang ;
Chia-Ying Lin ;
Yi-Shan Tsai ;
Chien-Kuo Wang ;
Ming-Ching Ou .
BMC Gastroenterology, 18
[38]   Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma [J].
Liu, Yi-Sheng ;
Lin, Chia-Ying ;
Chuang, Ming-Tsung ;
Tsai, Yi-Shan ;
Wang, Chien-Kuo ;
Ou, Ming-Ching .
BMC GASTROENTEROLOGY, 2018, 18
[39]   Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma [J].
Kyoko Oura ;
Asahiro Morishita ;
Takushi Manabe ;
Kei Takuma ;
Mai Nakahara ;
Tomoko Tadokoro ;
Koji Fujita ;
Shima Mimura ;
Joji Tani ;
Masafumi Ono ;
Takayuki Sanomura ;
Yoshihiro Nishiyama ;
Takashi Himoto ;
Hideki Kobara .
Scientific Reports, 15 (1)
[40]   TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA [J].
YANG, CF ;
HO, YZ ;
CHANG, JM ;
CHIANG, RH ;
LAI, KH ;
LEE, SD ;
TSAI, YT ;
LUI, WY ;
LIU, TJ ;
CHEN, GH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 :S26-S28
12345